Thomas Hayhow

Astra Zeneca

Sara Pannilunghi

University of Geneva

Sara Pannilunghi received her degree in Pharmacy with a Master in Pharmaceutical Chemistry and Technology from the University of Bologna (Italy) in 2018. After a brief experience with the solid-state synthesis of anti-VEGF peptides (Paris Descartes University), she contributed during her Master’s thesis to developing novel α-Carboline inhibitors of the Anaplastic Lymphoma Kinase (University of Geneva). In late 2018, Sara started a Ph.D. in Medicinal Chemistry and Biochemistry in Prof. L. Scapozza’s group at the University of Geneva. Her current project focuses on the conception, synthesis, and biological evaluation of Proteolysis Targeting Chimeras (PROTACs) employed against drivers of chronic inflammation.

Sandra Kumper

GSK

Riccardo De Matos Simoes

DFCI

Matthias Brand

Founder

Proxygen

Leah Fung

Biothery

Gaoqi Weng

Zhejiang University

Fu-Sen Liang

Case Western Reserve University

Elmar Wolf

Professor

University of Wurzbug

Constantine Mitsiades

DFCI